  Upcoming Events
May 16 – 17, 2013
Convergence Forum East Wequassett Resort & Golf Club Chatham, MA Robert Gould Convergence Forum East
May 24, 2013
Biochemical Pharmacology Discussion Group: Targeting Epigenetic Regulators for Cancer Therapy Friday, May 24th, at 8:30 AM NY Academy of Sciences New York, NY Robert Copeland Drugging the Human Methylome: Discovery and Characterization of Inhibitors of Protein Methyltransferases for the Treatment of Genetically Defined Cancers
June 5 - 6, 2013
Bayer HealthCare Life Science Workshop Thursday, June 6th, at 9:55 AM Berlin, Germany Robert Copeland “Protein Methyltransferases as a Target Class for Drug Discovery: Chemogenetic Analysis of DOT1L and EZH2 Interactions with Small Molecules” Bayer HealthCare Life Science Workshop
June 11 – 12, 2013
2013 Boston CEO Conference Wednesday, June 12th, at 1:00 PM Four Seasons Hotel Boston, MA Jason Rhodes “Panel: Deal Structures” 2013 Boston CEO Conference
June 19 - 22, 2013
AACR Special Conference on Chromatin and Epigenetics in Cancer Loews Atlanta Hotel Atlanta, GA Jesse Smith Friday, June 21st, at 4:30 PM “Panel: Inferring Mechanism from Human Genetics and Genomic Analysis of Cancer” Saturday, June 22nd, at 10:15 AM “Drugging the Epigenome” AACR Special Conference on Chromatin and Epigenetics in Cancer
July 17 – 20, 2013
2013 Zing Medicinal Chemistry Conference Silverado Resort and Spa Napa Valley, CA Robert Gould 2013 Zing Medicinal Chemistry Conference
July 24 – 26, 2013
EpiCongress Boston Boston, MA Wednesday, July 24th, at 8:30 AM Robert Gould “Keynote Session” “What might clinical biomarkers look like for this generation of epigenetic drugs?” EpiCongress Boston
September 17 – 19, 2013
BioPharm America Conference Tuesday, September 17 Westin Boston Waterfront Boston, MA Roundtable: “Partnering—thinking beyond the deal” BioPharm America Conference Past Events
April 2 – 3, 2013
2013 BD Biotech Wednesday, April 3rd, at 2 PM Four Seasons Boston, MA Jason Rhodes “Panel: Patient Perspectives” 2013 BD Biotech
April 6 – 10, 2013
AACR Annual Meeting Monday, April 8th, at 8 AM Walter E. Washington Convention Center Washington, DC Robert Copeland “Drugging the Human Methylome: Discovery and Characterization of Inhibitors of Protein Methyltransferases for the Treatment of Genetically Defined Cancers” AACR Annual Meeting
April 21 – 26, 2013
Gordon Research Conference: Cancer Genetics & Epigenetics Thursday, April 25th, at 9:35 AM Renaissance Tuscany Il Ciocco Resort Lucca (Barga), Italy Roy Pollock "Targeting Histone Methyltransferases in Cancer Therapy" Gordon Research Conference: Cancer Genetics & Epigenetics
April 22 – 25, 2013
BIO International Convention Wednesday, April 24th, at 10:30 AM McCormick Place Chicago, Il Robert Gould “Panel: Epigenetics: More than a Mere Expression” BIO International Convention July 10 - 11, 2011 Epigenomics, Sequencing & SNiPs-2011 The Joseph B. Martin Conference Center at Harvard Medical School Boston, MA July 11: Robert A. Copeland, Ph.D. "Protein Methyltransferase Inhibitors as Personalized Cancer Therapeutics" Epigenomics, Sequencing & SNiPs-2011
July 10 - 15, 2011 Gordon Research Conferences: Enzymes, Coenzymes & Metabolic Pathways Waterville Valley Resort Waterville Valley, NH ENZYMOLOGY OF EPIGENETICS Monday, July 11: Victoria Richon "Histone methyltransferases: A new target class for cancer drug discovery"
July 27 - 28, 2011 World Epigenetics Summit KEYNOTE: "Unlocking the Potential of Epigenetic Drug Products" Dr. Robert Gould "Protein Methyl Transferases: A Novel Target Class for Molecularly Targeted Therapy against Genetically Defined Cancers" Dr. Mike Moyer "Investing in Epigenetics: What are the Opportunities?" Dr. Robert Gould Boston, MA World Epigenetics Forum Agenda
July 28-29, 2011 The NCI Translational Science Meeting 2011: From Molecular Information to Cancer Medicine Washington Marriott Wardman Park Washington, DC Friday, July 29: Victoria Richon "The Impact of Comprehensive Genomics in New Treatments for Acute Lymphoblastoid Leukemia (ALL)" From Molecular Information to Cancer Medicine
September 6, 2011 MassBio Business Development Committee Meeting MassBio Cambridge, MA Jason Rhodes Panel: “Bridging the Gap Between the Sell- and Buy-sides: Current Approaches Versus Best Practice” MassBio Business Development Committee Meeting
September 9, 2011 BioPharm America 2011 Westin Boston Waterfront Hotel Boston, MA Robert Gould "Histone methyltransferases: A new target class for cancer drug discovery"
September 9, 2011 Stifel Nicolaus 2011 Healthcare Conference The Four Seasons Hotel Boston, MA Jason Rhodes
September 9 – 11, 2012 Rodman & Renshaw 14th Annual Healthcare Conference Monday, September 10th, at 2:25 PM Waldorf Astoria New York, NY Jason Rhodes “Company Presentation” Rodman & Renshaw 14th Annual Healthcare Conference
October 12, 2011 Mid-Atlantic Bio Symposium Carnegie Institution for Science Washington, DC Robert Gould
October 20, 2011 New England Structural Biology Association Bentley University Waltham, MA Robert Copeland New England Structural Biology Association
October 20 - 22, 2011 Nature Chemical Biology Symposium 2011: Cancer Chemical Biology Royal Sonesta Hotel Boston Cambridge, MA Victoria Richon Nature Chemical Biology Symposium 2011
October 25 – 26, 2011 10th Annual BIO Investor Forum Palace Hotel San Francisco, CA Robert Gould 10th Annual BIO Investor Forum
October 26 - 28, 2011 CETF Think Tank Lansdowne Resort Leesburg, VA Victoria Richon
November 3 - 6, 2011 William Guy Forbeck Research Foundation Epigenetics & Drug Therapy Annual Forum Moss Creek Plantation Hilton Head Island, South Carolina Victoria Richon William Guy Forbeck Research Foundation
November 15 – 16, 2011 Lazard Capital Markets 8th Annual Healthcare Conference The Pierre Hotel New York, NY 10065 Jason Rhodes "Company Presentation"
December 7, 2011 2nd World Epigenetics Summit Munich, Germany Robert Copeland
December 8, 2011 Convergence Forum West Hotel Vitale San Francisco, CA Robert Gould
January 11 - 12, 2012 New Paradigms Conference Marines’ Memorial Club & Hotel San Francisco, CA Robert Gould "Sharing the Journey of Growth and Lessons Learned"
January 23 – 24, 2012 PMWC 2012 Most Promising Company Competition Computer History Museum Mountain View, CA Robert Gould PMWC 2012 Most Promising Company Competition
February 15 – 16, 2012 Leerink Swann 2012 Global Healthcare Conference The Waldorf Astoria Hotel New York City, NY Robert Gould "Company Presentation" Wednesday, February 15th – 2:00 PM
February 27 – 28, 2012 GTC’s Oncology Partnering & Deal-making Conference Red Rock Casino Resort and Spa Las Vegas, NV Jason Rhodes Featured Joint Presentation: Investments, Partnerships & Acquisitions: Trends & Recent Deal Monday, February 27th – 8:00 AM Panel Discussion: Investments, Partnerships & Acquisitions: Trends & Recent Deal Monday, February 27th – 10:55 AM GTC’s Oncology Partnering & Deal-making Conference
February 27-29th, 2012 Citi 2012 Global Healthcare Conference Waldorf Astoria Hotel New York City, NY Robert Gould Tuesday, February 28th – 4:00 PM
March 5 – 7, 2012 32nd Annual Cowen Health Care Conference Boston Marriott Copley Place Boston, MA Jason Rhodes "Company Presentation" Monday, March 5th – 12:00 Noon
March 6 - 7, 2012 23rd Annual Cancer Progress Conference The Westin New York at Times Square New York, NY Robert Copeland 23rd Annual Cancer Progress Conference
March 19 – 23, 2012 Keystone Symposia: Addressing the Challenges of Drug Discovery – Novel Targets, New Chemical Space and Emerging Approaches Granlibakken Resort Tahoe City, CA Robert Copeland "Protein Methyltransferase Inhibitors as Personalized Cancer Therapeutics"
March 25 – 29, 2012 ACS Spring 2012 National Meeting & Exposition San Diego Convention Center San Diego, CA Robert Copeland "Epigenetics: From Basic Principles to Drug Development" ACS Spring 2012 National Meeting & Exposition
March 28 – 29, 2012 Boston Biotech: Shanghai CEO Conference The Peninsula Shanghai Shanghai, China Robert Gould Boston Biotech: Shanghai CEO Conference
March 28 - 30, 2012 Epigenetic Drug Discovery Freiburg Institute for Advanced Studies Freiburg, Germany Victoria Richon "Novel Enzyme Targets" March 31 – April 4, 2012 AACR Annual Meeting 2012 McCormick Place Chicago, IL Robert Copeland Victoria Richon
April 11 – 13, 2012 Pharmaceutical Strategic Outlook Conference Grand Hyatt New York New York City, NY Jason Rhodes Pharmaceutical Strategic Outlook Conference
April 13, 2012 Molecular & Translational Breakthroughs in Leukemia Research Symposium The University of Chicago Comprehensive Cancer Center: Knapp Center for Biomedical Discovery Chicago, IL Victoria Richon "Personalized Treatment for MLL-rearranged Leukemia Based on Potent, Selective Inhibition of DOT1L" Molecular & Translational Breakthroughs in Leukemia Research Symposium
April 17 - 18, 2012 BD Biotech Conference Mandarin Oriental Hotel Boston, MA Jason Rhodes, Co-Host
April 19, 2012 19th Annual Future Leaders in the Biotech Industry Investment Conference Millennium Broadway Hotel & Conference Center New York City, NY Jason Rhodes "Company Presentation"
April 25 – 26, 2012 Lineberger Cancer Symposium University of North Carolina Chapel Hill, NC Robert Copeland
May 1 - 2, 2012 Deloitte Recap’s Allicense 2012 Conference Palace Hotel San Francisco, CA Jason Rhodes Deloitte Recap’s Allicense 2012 Conference
May 3, 2012 The Bioscience Network: The Money of Invention- Current Trends in Development Capital in Biotech Broad Institute Cambridge, MA Jason Rhodes Panel: The Money of Invention- Experimenting with The Biotech Capital Risk Capital Model The Bioscience Network: The Money of Invention- Current Trends in Development Capital in Biotech
May 16, 2012 Licensing Executives Society USA & Canada, Inc. (LES) 2012 Spring Meeting Hyatt Regency Boston Boston, MA Jason Rhodes Panel: Finding the Right Time to Partner: Can You Maximize Value While Balancing Risk and Reward? Licensing Executives Society USA & Canada, Inc. (LES) 2012 Spring Meeting
May 21 – 22, 2012 SPI 2012: Science, Partnering and Investment Forum, Gateway for the Global Life Sciences Palm Beach County Convention Center West Palm Beach, FL Robert Gould SPI 2012: Science, Partnering and Investment Forum, Gateway for the Global Life Sciences
May 30 – 31, 2012 Omics Evolution Summit: 2nd Epigenetics in Drug Discovery Conference Hyatt Harborside Boston, MA Mikel Moyer Omics Evolution Summit: 2nd Epigenetics in Drug Discovery Conference
June 3 - 6, 2012 4th Trends in Enzymology (TinE 2012) Conference "Alte Mensa" at the Wilhelmsplatz Göttingen, Germany Robert Copeland "Protein Methyltransferase Inhibitors as Personalized Cancer Therapeutics"
June 6 – 8, 2012 12th Annual Structure-Based Drug Design Conference Royal Sonesta Hotel Cambridge, MA Robert Copeland 12th Annual Structure-Based Drug Design Conference
June 11 — 12, 2012 2012 CEO Biotech Mandarin Oriental Boston Boston, MA Jason Rhodes Panel: Deal Structures
June 14, 2012 Summer Symposium 2012: Epigenetics, Plasticity, and Cancer The David H. Koch Institute for Integrative Cancer Research Cambridge, MA Victoria Richon Summer Symposium 2012: Epigenetics, Plasticity, and Cancer
June 18 – 21, 2012 2012 BIO International Convention Boston Convention & Exhibition Center Boston, MA Jason Rhodes 2012 BIO International Convention
July 15 – 19, 2012 Molecular Therapeutics of Cancer 2012 Conference Princeton University Princeton, NJ Victoria Richon
July 24 – 26, 2012
3rd World Epigenetics Summit W Hotel Boston, MA Robert Copeland August 14 - 15, 2012 Wedbush 2012 Life Sciences: Management Access Conference Wednesday, August 15th, at 3:40 PM Le Parker Meridien Hotel New York, NY Wedbush 2012 Life Sciences: Management Access Conference
September 5 – 6, 2012 ELRIG (European Laboratory Robotics Interest Group) Drug Discovery 2012Thursday, September 6th The Manchester Central Conference Centre Manchester, United Kingdom Margaret Porter Scott “Meeting the Challenges of Drug Discovery in Novel Target Space: Development of Physiologically-Relevant Screening Assays for Epigenetic Targets” ELRIG (European Laboratory Robotics Interest Group) Drug Discovery 2012
September 5 – 7, 2012 Stifel Nicolaus Healthcare Conference Wednesday, September 5th, at 2:05 PM Four Seasons Hotel Boston Boston, MA Robert Gould “Company Presentation” Stifel Nicolaus Healthcare Conference
September 17 – 19, 2012 Pharmaceutical Strategic AlliancesWednesday, September 19th, at 8:40 AM Marriott Marquis New York, NY Jason Rhodes Panel: Building Biotech Value: New Models for Modern Times Pharmaceutical Strategic Alliances
September 19–21, 2012 BioPharm America 2012 Wednesday, September 19th, at 11 AM: Panel: “Who is the best player in the value chain?” Thursday, September 20th: “Company Presentation” Westin Boston Waterfront Hotel Boston, MA Robert Gould BioPharm America 2012
September 27 – 28, 2012 2012 Mid-Atlantic Bio Conference Thursday, September 27th, at 3:20 PM Bethesda North Marriott and Conference Center Bethesda, Maryland Eric Hedrick Panel: Biomarkers, Diagnostics and Personalized Medicine: to Oncology and Beyond2012 Mid-Atlantic Bio Conference
October 1 – 3, 2012
10th Annual Discovery on Target: Targeting Histone Methyltransferases and Demethylases Wednesday, October 3rd, at 3:40 PM Copley Marriott Hotel Boston, MA Roy Pollock “Targeting Histone Methyltransferases in Cancer Therapy” 10th Annual Discovery on Target: Targeting Histone Methyltransferases and DemethylasesOctober 9 – 10, 2012 BIO Investor ForumWednesday, October 10th, at 10 AM Palace Hotel San Francisco, CA Jason Rhodes “Company Presentation” BIO Investor Forum October 14 – 17, 2012 2012 LES (Licensing Executives Society) Annual MeetingMonday, October 15th Sheraton Centre Toronto Toronto, Ontario, Canada Zoran Zdraveski 2012 LES (Licensing Executives Society) Annual Meeting October 14 – 19, 2012 10th Swiss Course on Medicinal ChemistryTuesday, October 16th, at 5:30 PM Leysin, Switzerland Robert Copland “Lecture: Epigenetics” 10th Swiss Course on Medicinal Chemistry
November 1, 2012
2012 New York CEO Biotech Conference Thursday, November 1st, at 5:00 PM Apella New York City, NY Jason Rhodes Panel: The Future of Structuring Deals2012 New York CEO Biotech Conference
November 8 – 9, 2012
2nd Cancer Epigenetics Conference Friday, November 9th, at 8:35 AM Park Plaza Hotel & Towers Boston, MA Robert Copeland “Keynote Presentation: Protein Methyltransferase Inhibitors an Personalized Cancer Therapeutics” 2nd Cancer Epigenetics Conference
November 13 – 14, 2012
Lazard Capital Markets 9th Annual Healthcare Conference The Pierre Hotel New York, NY 10065 Robert Gould “Company Presentation”Lazard Capital Markets 9th Annual Healthcare Conference
November 16, 2012
New England Structural Biology Association Bentley University Waltham, MA Robert Copeland New England Structural Biology Association
November 27 – 28, 2012
Piper Jaffray 24th Annual Healthcare Conference Tuesday, November 27th, at 10:30 AM New York Palace Hotel New York, NY Robert Gould “Company Presentation” Piper Jaffray 24th Annual Healthcare Conference
December 2 – 4, 2012
Pharmaceuticals & Biotechnology IP Forum PGA National Resort & Spa Palm Beach Gardens, FL Zoran Zdraveski Pharmaceuticals & Biotechnology IP Forum
December 2 – 4, 2012
Pharmaceuticals & Biotechnology IP Forum PGA National Resort & Spa Palm Beach Gardens, FL Zoran Zdraveski Pharmaceuticals & Biotechnology IP Forum
December 4 – 6, 2012
4th World Epigenetic Summit Wednesday, December 5th, at 2:30 PM Doubletree by Hilton Hotel London – West End London, United Kingdom Robert Copeland “Harnessing HMT Inhibition Uncovers a New Avenue in Epigenetic Cancer Therapy” 4th World Epigenetic Summit
January 6, 2013
San Francisco CEO Conference Sunday, January 6th, at 11 AM Four Seasons Hotel San Francisco, CA Robert Gould Panel: Private FinancingSan Francisco CEO Conference
January 6 – 10, 2013
JP Morgan Chase 31st Annual Healthcare Conference Tuesday, January 8th, at 8 AM PT Westin St. Francis San Francisco, CA Robert Gould “Company Presentation”
January 20 - 24, 2013
11th Winter Conference on Medicinal and Bioorganic Chemistry Wednesday, January 23rd, at 4:40 PM Sheraton Steamboat Springs Resort Steamboat Springs, CO Ed Olhava “Studies Leading to the Clinical Candidate EPZ-5676, a DOT1L Inhibitor for the Treatment of MLL-rearranged Leukemia” 11th Winter Conference on Medicinal and Bioorganic Chemistry
February 1, 2013
2013 State of the Life Sciences Industry Yale Alumni & Student Reception Red Thread Boston, MA Jason Rhodes 2013 State of the Life Sciences Industry Yale Alumni & Student Reception
February 13 – 14, 2013
Boston Biotech New York CEO Conference Apella New York, NY Thursday, February 14th at 12:30 pm Jason Rhodes "The Future of Structuring Deals" Boston Biotech New York CEO Conference
February 13 – 14, 2013
Leerink Swann Global Healthcare Conference Waldorf Astoria New York, NY Wednesday, February 13th at 2:00 pm Robert Gould “Company Presentation”
March 4 - 6, 2013
Tuesday, March 5th, at 1:30 PM TAT 2013 Congress Marriott Rive Gauche Hotel & Conference Center Paris, France Heike Keilhack “Targeting EZH2”TAT 2013 Congress
March 5 - 6, 2013
24th Annual Cancer Progress Conference Conrad New York New York, NY Tuesday, March 5th, at 10:45 AM Eric Hedrick “Panel: Changing AML Outcomes via Personalized Medicine: Transforming Cancer Management with Genetic Insight” Wednesday, March 6th, at 10:15 AM Robert Gould “Panel: Epigenetics – Are we there yet? Building on the Foundations of DNMT and HDAC Inhibitors”
March 13 - 15, 2013
9th Annual Pharma/Biotech Accounting and Reporting Congress Friday, March 15th, at 11:30 AM Hyatt Regency Philadelphia, PA Stephen Garbacz “Strategies for Ensuring Effective IPO-Readiness” 9th Annual Pharma/Biotech Accounting and Reporting Congress
March 18, 2013
PreClinical Summit World Asia Resorts World Sentosa 6th Annual BioPharma Asia Convention 2013
March 19 - 20, 2013
6th Annual BioPharma Asia Convention 2013 Resorts World Sentosa Singapore “Panel: Refining partnerships for preclinical research in Asia” Angelos Dovletoglou 6th Annual BioPharma Asia Convention 2013
March 19 - 20, 2013
Informa LifeScience's Drug Discovery Innovations 2013 Tuesday, March 19th Maritim proArte Hotel Berlin, Germany Margaret Porter Scott “Histone Methyltransferases as a Target Class for Drug Discovery”Informa LifeScience's Drug Discovery Innovations 2013
March 20, 2013
University of Toledo Annual Research Forum 2013 University of Toledo College of Medicine Toledo, OH Robert Copeland University of Toledo Annual Research Forum 2013
March 21 – 25, 2013
Keystone Symposium: Epigenetic Marks and Cancer Drugs Sunday, March 24th, at 5 PM Eldorado Hotel & Spa Santa Fe, NM Robert Gould “Drugging the Human Methylome: Discovery and Characterization of Inhibitors of Protein Methyltransferases for the Treatment of Genetically Defined Cancers” Keystone Symposium: Epigenetic Marks and Cancer Drugs
|
